Glenmark Pharmaceuticals Market Cap

Glenmark Pharmaceuticals has a market cap or net worth of 480.48 billion as of September 6, 2024. Its market cap has increased by 122.24% in one year.

Market Cap

480.48B

Enterprise Value

476.19B

Revenue

128.61B

Ranking

n/a

PE Ratio

n/a

Stock Price

1,702.70

Market Cap Chart

Since June 7, 2001, Glenmark Pharmaceuticals's market cap has increased from 1.15B to 480.48B, an increase of 41,706.35%. That is a compound annual growth rate of 29.62%.

Market Cap History

Date	Market Cap	% Change
Sep 6, 2024	480.48B	99.41%
Dec 29, 2023	240.96B	101.33%
Dec 30, 2022	119.68B	-19.75%
Dec 31, 2021	149.14B	7.10%
Dec 31, 2020	139.25B	42.03%
Dec 31, 2019	98.04B	-49.87%
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro
Dec 31, 2014	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Reliance Industries Limited	19.82T
Tata Consultancy Services Limited	16.12T
HDFC Bank Limited	12.48T
Bharti Airtel Limited	9,202.60B
ICICI Bank Limited	8,511.22B
Infosys Limited	7,877.25B
State Bank of India	6,983.51B
Hindustan Unilever Limited	6,669.20B

Market Cap Rankings